Bempedoic acid for the treatment of dyslipidemia

Cardiovascular disease (CVD) is the leading cause of death worldwide and one key factor associated with the increased CVD risk is dyslipidemia. Statin therapy remains the first-line treatment to manage dyslipidemia, yet many patients do not achieve optimal low-density lipoprotein-cholesterol (LDL-C)...

Descripción completa

Detalles Bibliográficos
Autores principales: Marrs, Joel C, Anderson, Sarah L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449648/
https://www.ncbi.nlm.nih.gov/pubmed/32922503
http://dx.doi.org/10.7573/dic.2020-6-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449648/
https://www.ncbi.nlm.nih.gov/pubmed/32922503
http://dx.doi.org/10.7573/dic.2020-6-5

Ejemplares similares